Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications

详细信息    查看全文

• 作者：Mingyue Cai ; Wensou Huang ; Chaoshuang Lin ; Zhengran Li ; Jiesheng Qian…
• 关键词：Partial splenic embolization ; Thrombocytopenia ; Predictor ; Efficacy ; Complication
• 刊名：European Radiology
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：26
• 期：2
• 页码：370-380
• 全文大小：1,567 KB
• 参考文献：1.Poordad F (2007) Review article: thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther 26:5–11PubMed CrossRef
  2.Afdhal N, McHutchison J, Brown R et al (2008) Thrombocytopenia associated with chronic liver disease. J Hepatol 48:1000–1007PubMed CrossRef
  3.Fouad YM (2013) Chronic hepatitis C-associated thrombocytopenia: aetiology and management. Trop Gastroenterol 34:58–67PubMed CrossRef
  4.Sangro B, Bilbao I, Herrero I et al (1993) Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology 18:309–314PubMed CrossRef
  5.Zhu K, Meng X, Li Z et al (2008) Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study. Eur J Radiol 66:100–106PubMed CrossRef
  6.Zhu K, Meng X, Qian J et al (2009) Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients. Dig Liver Dis 41:411–416PubMed CrossRef
  7.Amin MA, El-Gendy MM, Dawoud IE, Shoma A, Negm AM, Amer TA (2009) Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients. World J Surg 33:1702–1710PubMed CrossRef
  8.Palsson B, Verbaan H (2005) Partial splenic embolization as pretreatment for antiviral therapy in hepatitis C virus infection. Eur J Gastroenterol Hepatol 17:1153–1155PubMed CrossRef
  9.Noguchi H, Hirai K, Aoki Y, Sakata K, Tanikawa K (1995) Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism. Hepatology 22:1682–1688PubMed CrossRef
  10.Hayashi H, Beppu T, Masuda T et al (2007) Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients. J Gastroenterol Hepatol 22:1638–1642PubMed CrossRef
  11.Hayashi H, Beppu T, Okabe K et al (2010) Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis. J Gastroenterol 45:554–559PubMed CrossRef
  12.N'Kontchou G, Seror O, Bourcier V et al (2005) Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol 17:179–184PubMed CrossRef
  13.Vujic I, Lauver JW (1981) Severe complications from partial splenic embolization in patients with liver failure. Br J Radiol 54:492–495PubMed CrossRef
  14.Sakai T, Shiraki K, Inoue H et al (2002) Complications of partial splenic embolization in cirrhotic patients. Dig Dis Sci 47:388–391PubMed CrossRef
  15.Hayashi H, Beppu T, Okabe K, Masuda T, Okabe H, Baba H (2008) Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg 95:744–750PubMed CrossRef
  16.Cai M, Zhu K, Huang W et al (2013) Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up. J Vasc Interv Radiol 24:1808–1816PubMed CrossRef
  17.Alwmark A, Bengmark S, Gullstrand P, Joelsson B, Lunderquist A, Owman T (1982) Evaluation of splenic embolization in patients with portal hypertension and hypersplenism. Ann Surg 196:518–524PubMed PubMedCentral CrossRef
  18.Koizumi J, Itou C, Wray R et al (2013) Partial splenic embolisation using n-butyl cyanoacrylate: intraprocedural evaluation by magnetic resonance imaging. Eur Radiol 23:1429–1442PubMed CrossRef
  19.Hidaka H, Kokubu S, Saigenji K, Isobe Y, Maeda T (2002) Restoration of thrombopoietin production after partial splenic embolization leads to resolution of thrombocytopenia in liver cirrhosis. Hepatol Res 23:265PubMed CrossRef
  20.Angle JF, Siddiqi NH, Wallace MJ et al (2010) Quality improvement guidelines for percutaneous transcatheter embolization: Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol 21:1479–1486PubMed CrossRef
  21.Meng F, Yin X, Ma X, Guo XD, Jin B, Li H (2013) Assessment of the value of serum cholinesterase as a liver function test for cirrhotic patients. Biomed Rep 1:265–268PubMed PubMedCentral
  
• 作者单位：Mingyue Cai (1)
  Wensou Huang (1)
  Chaoshuang Lin (2)
  Zhengran Li (1)
  Jiesheng Qian (1)
  Mingsheng Huang (1)
  Zhaolin Zeng (1)
  Jingjun Huang (1)
  Hong Shan (1)
  Kangshun Zhu (1)
  
  1. Department of Radiology, the Third Affiliated Hospital, and Interventional Radiology Institute, Sun Yat-sen University, 600 Tianhe Road, Guangzhou, Guangdong, 510630, China
  2. Department of Infectious Diseases, the Third Affiliated Hospital, Sun Yat-sen University, 600 Tianhe Road, Guangzhou, Guangdong, 510630, China
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Imaging and Radiology
  Diagnostic Radiology
  Interventional Radiology
  Neuroradiology
  Ultrasound
  Internal Medicine
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1432-1084

文摘

Objectives To investigate the predictors of platelet increment and risk factors for major complications after partial splenic embolization (PSE) in cirrhosis.